Cargando…
Autologous hematopoietic transplantation following COVID‐19 infection
Autologous hematopoietic cell transplantation following induction therapy is standard of care for most patients with newly diagnosed multiple myeloma (N Engl J Med 2017, 376; 1311). Though active COVID‐19 infection is typically a contraindication to aggressive therapy, little is known about the safe...
Autores principales: | Brzycki, Marthilde, Richard, Robert, Burwick, Nicholas, Graf, Solomon, O'Brien, Craig, Wu, Daniel, Chauncey, Thomas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981617/ https://www.ncbi.nlm.nih.gov/pubmed/33768803 http://dx.doi.org/10.1002/ccr3.3712 |
Ejemplares similares
-
Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience
por: Wu, Aaron, et al.
Publicado: (2020) -
Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS)
por: Klocke, Heather, et al.
Publicado: (2020) -
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma
por: Maffini, Enrico, et al.
Publicado: (2019) -
Assessing Cachexia Acutely after Autologous Stem Cell Transplant
por: Anderson, Lindsey J., et al.
Publicado: (2019) -
SUN-230 Association of Estrogens and Androgens with Sexual Function after Hematopoietic Stem Cell Transplant
por: Anderson, Lindsey, et al.
Publicado: (2019)